Yestar Healthcare Holdings Company Limited provided earnings guidance for the six months ended 30 June 2020. The company is expected to record an unaudited consolidated net loss of the Group of not less than RMB 700 million and an unaudited consolidated net loss attributable to the owners of the parent of not less than RMB 600 million for the Interim Period 2020 as compared to an unaudited consolidated net profit of the Group of approximately RMB 200.6 million and an unaudited consolidated net profit attributable to the owners of the parent of approximately RMB 142.0 million for the six months ended 30 June 2019.